NLRP3 inflammasome activation in type 2 diabetic patients: role of glycaemic control
Por:
Iannantuoni, F, Martinez de Maranon, A, Escribano-Lopez, I, Lopez-Domenech, S, Abad-Jimenez, Z, Salom, C, Jover, A, Mora, V, Roldan, I, Sola, E, Rocha, M and Victor, V
Publicada:
1 ago 2019
Resumen:
|